|
OMIM |
Link |
Information gain |
01 |
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.01244
|
|
|
IDDM
|
[NCBI]
|
0.0050228
|
|
|
APS2
|
[NCBI]
|
0.00142888
|
|
|
PNDM
|
[NCBI]
|
0.00116944
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.00082429
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.00082429
|
|
|
MODY
|
[NCBI]
|
0.000707549
|
|
|
GIP
|
[NCBI]
|
0.000612381
|
|
|
CPAF
|
[NCBI]
|
0.000611009
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000607155
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000607155
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000607155
|
|
|
brachial palsy, familial congenital
|
[NCBI]
|
0.000607155
|
|
|
MAFD4
|
[NCBI]
|
0.000607155
|
|
|
ALMS
|
[NCBI]
|
0.000571155
|
|
|
hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome
|
[NCBI]
|
0.000525712
|
|
|
CHDS8
|
[NCBI]
|
0.000525712
|
|
|
facial palsy, familial recurrent peripheral
|
[NCBI]
|
0.000525712
|
|
|
IAPP
|
[NCBI]
|
0.000510318
|
|
|
INS
|
[NCBI]
|
0.000503931
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000491458
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
0.000473596
|
|
|
FPLD1
|
[NCBI]
|
0.000473112
|
|
|
CELIAC6
|
[NCBI]
|
0.000473112
|
|
|
PCOS1
|
[NCBI]
|
0.000426977
|
|
|
CF
|
[NCBI]
|
0.00040271
|
|
|
AKR1B1
|
[NCBI]
|
0.000390623
|
|
|
SLC19A2
|
[NCBI]
|
0.000318531
|
|
|
NIDDM
|
[NCBI]
|
0.000310038
|
|
|
IBD5
|
[NCBI]
|
0.000305681
|
|
|
TRMA
|
[NCBI]
|
0.000294159
|
|
|
MTTL1
|
[NCBI]
|
0.000279207
|
|
|
KCNJ11
|
[NCBI]
|
0.000271057
|
|
|
FPLD2
|
[NCBI]
|
0.000242244
|
|
|
AGER
|
[NCBI]
|
0.000225697
|
|
|
WFS1
|
[NCBI]
|
0.00021662
|
|
|
IPEX
|
[NCBI]
|
0.000211742
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
0.000196864
|
|
|
diabetes mellitus, transient neonatal, 2
|
[NCBI]
|
0.000188217
|
|
|
LEPR
|
[NCBI]
|
0.000184184
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000183984
|
|
|
HP
|
[NCBI]
|
0.000179397
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
0.000173463
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
0.00016906
|
|
|
PLAGL1
|
[NCBI]
|
0.000155304
|
|
|
SLC2A4
|
[NCBI]
|
0.000153627
|
|
|
RA
|
[NCBI]
|
0.000151227
|
|
|
GCK
|
[NCBI]
|
0.000145414
|
|
|
MAFD1
|
[NCBI]
|
0.000142233
|
|
|
CEACAM5
|
[NCBI]
|
0.000138687
|
|
|
VRNI
|
[NCBI]
|
0.000135576
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
0.000133813
|
|
|
PPARA
|
[NCBI]
|
0.000131506
|
|
|
IPF1
|
[NCBI]
|
0.000124905
|
|
|
UCP2
|
[NCBI]
|
0.00012411
|
|
|
KLK3
|
[NCBI]
|
0.000115159
|
|
|
HNF1B
|
[NCBI]
|
0.000111725
|
|
|
MTTE
|
[NCBI]
|
0.000109992
|
|
|
EGFR
|
[NCBI]
|
0.000109897
|
|
|
HBB
|
[NCBI]
|
0.00010479
|
|
|
SLE
|
[NCBI]
|
0.000104674
|
|
|
INSR
|
[NCBI]
|
9.99876e-05
|
|
|
IRDN
|
[NCBI]
|
9.56943e-05
|
|
|
hexokinase of spermatozoa
|
[NCBI]
|
9.40783e-05
|
|
|
diabetes mellitus, neonatal, with congenital hypothyroidism
|
[NCBI]
|
9.40783e-05
|
|
|
renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial dna
|
[NCBI]
|
9.40783e-05
|
|
|
edema, familial idiopathic, prepubertal
|
[NCBI]
|
9.40783e-05
|
|
|
premature aging syndrome, okamoto type
|
[NCBI]
|
9.40783e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
9.33677e-05
|
|
|
HHF2
|
[NCBI]
|
9.20997e-05
|
|
|
HYMAI
|
[NCBI]
|
8.93038e-05
|
|
|
LEP
|
[NCBI]
|
8.85173e-05
|
|
|
PTPN1
|
[NCBI]
|
8.82878e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
8.72102e-05
|
|
|
NPY
|
[NCBI]
|
8.62126e-05
|
|
|
INSIG1
|
[NCBI]
|
8.07675e-05
|
|
|
PTF1A
|
[NCBI]
|
8.07675e-05
|
|
|
APOB
|
[NCBI]
|
8.06421e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
8.05477e-05
|
|
|
LMNA
|
[NCBI]
|
7.98553e-05
|
|
|
TNF
|
[NCBI]
|
7.96933e-05
|
|
|
MADA
|
[NCBI]
|
7.50863e-05
|
|
|
LPL
|
[NCBI]
|
7.32589e-05
|
|
|
HNF1A
|
[NCBI]
|
7.28618e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
7.26873e-05
|
|
|
hepatic adenomas, familial
|
[NCBI]
|
7.16545e-05
|
|
|
pancreatic beta cell agenesis with neonatal diabetes mellitus
|
[NCBI]
|
7.16545e-05
|
|
|
MODY8
|
[NCBI]
|
7.16545e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
7.16545e-05
|
|
|
ABCC8
|
[NCBI]
|
7.1599e-05
|
|
|
GCGR
|
[NCBI]
|
7.04505e-05
|
|
|
AFP
|
[NCBI]
|
6.82715e-05
|
|
|
APS1
|
[NCBI]
|
6.69586e-05
|
|
|
CPE
|
[NCBI]
|
6.56136e-05
|
|
|
HBA1
|
[NCBI]
|
6.40358e-05
|
|
|
LDHB
|
[NCBI]
|
6.37808e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
6.32212e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
6.32212e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
6.32212e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
6.32212e-05
|
|
|
LDHCP
|
[NCBI]
|
6.32212e-05
|
|
|
FRDA
|
[NCBI]
|
6.17828e-05
|
|
|
PPARG
|
[NCBI]
|
6.01174e-05
|
|
|
PCNA
|
[NCBI]
|
5.98083e-05
|
|
|
PCTT
|
[NCBI]
|
5.83748e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
5.77618e-05
|
|
|
MODY4
|
[NCBI]
|
5.77618e-05
|
|
|
HHF3
|
[NCBI]
|
5.77618e-05
|
|
|
ADIPOR1
|
[NCBI]
|
5.67837e-05
|
|
|
TCF7L2
|
[NCBI]
|
5.46254e-05
|
|
|
fructosamine 3-kinase-related protein
|
[NCBI]
|
5.41136e-05
|
|
|
GLIS3
|
[NCBI]
|
5.41136e-05
|
|
|
MAFA
|
[NCBI]
|
5.41136e-05
|
|
|
fructosamine 3-kinase
|
[NCBI]
|
5.41136e-05
|
|
|
MIRN375
|
[NCBI]
|
5.41136e-05
|
|
|
transmembrane domain protein regulated in adipocytes, 40-kd
|
[NCBI]
|
5.41136e-05
|
|
|
NCB5OR
|
[NCBI]
|
5.41136e-05
|
|
|
earlobe crease
|
[NCBI]
|
5.37147e-05
|
|
|
FOXP3
|
[NCBI]
|
5.21727e-05
|
|
|
CGL1
|
[NCBI]
|
5.04995e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
5.04995e-05
|
|
|
KSS
|
[NCBI]
|
5.03372e-05
|
|
|
CCK
|
[NCBI]
|
4.96215e-05
|
|
|
EGF
|
[NCBI]
|
4.78301e-05
|
|
|
SLC2A1
|
[NCBI]
|
4.76769e-05
|
|
|
MPO
|
[NCBI]
|
4.64331e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
4.55591e-05
|
|
|
short syndrome
|
[NCBI]
|
4.55591e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
4.55591e-05
|
|
|
RETN
|
[NCBI]
|
4.54185e-05
|
|
|
MODY2
|
[NCBI]
|
4.35764e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
4.35764e-05
|
|
|
GFAP
|
[NCBI]
|
4.33481e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
4.18204e-05
|
|
|
WFS1
|
[NCBI]
|
4.15974e-05
|
|
|
UCP1
|
[NCBI]
|
4.13809e-05
|
|
|
POMC
|
[NCBI]
|
4.13605e-05
|
|
|
LCAT
|
[NCBI]
|
4.0377e-05
|
|
|
SNF1LK2
|
[NCBI]
|
4.03759e-05
|
|
|
SH2B3
|
[NCBI]
|
4.03759e-05
|
|
|
NKX2-2
|
[NCBI]
|
4.03759e-05
|
|
|
FGF21
|
[NCBI]
|
4.03759e-05
|
|
|
TRIB3
|
[NCBI]
|
4.03759e-05
|
|
|
SORCS1
|
[NCBI]
|
4.03759e-05
|
|
|
PTPN2
|
[NCBI]
|
4.03759e-05
|
|
|
CAV2
|
[NCBI]
|
4.03759e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
4.02455e-05
|
|
|
FFS
|
[NCBI]
|
3.88187e-05
|
|
|
PF4
|
[NCBI]
|
3.77132e-05
|
|
|
HGF
|
[NCBI]
|
3.73275e-05
|
|
|
ENPP1
|
[NCBI]
|
3.7058e-05
|
|
|
CLEC16A
|
[NCBI]
|
3.52175e-05
|
|
|
SEPS1
|
[NCBI]
|
3.52175e-05
|
|
|
ATG16L1
|
[NCBI]
|
3.52175e-05
|
|
|
MTTS2
|
[NCBI]
|
3.52175e-05
|
|
|
CRTC2
|
[NCBI]
|
3.52175e-05
|
|
|
MDD
|
[NCBI]
|
3.51592e-05
|
|
|
GCCR
|
[NCBI]
|
3.40051e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
3.32083e-05
|
|
|
SLC2A2
|
[NCBI]
|
3.24037e-05
|
|
|
SLC2A3
|
[NCBI]
|
3.18827e-05
|
|
|
CD1D
|
[NCBI]
|
3.18827e-05
|
|
|
FOXA2
|
[NCBI]
|
3.18827e-05
|
|
|
FABP4
|
[NCBI]
|
3.18827e-05
|
|
|
UCP3
|
[NCBI]
|
3.00323e-05
|
|
|
IGF2BP2
|
[NCBI]
|
2.9414e-05
|
|
|
FGF19
|
[NCBI]
|
2.9414e-05
|
|
|
IRGM
|
[NCBI]
|
2.9414e-05
|
|
|
MTPN
|
[NCBI]
|
2.9414e-05
|
|
|
GLO1
|
[NCBI]
|
2.9414e-05
|
|
|
P4HB
|
[NCBI]
|
2.9414e-05
|
|
|
ADIPOR2
|
[NCBI]
|
2.9414e-05
|
|
|
PBX1
|
[NCBI]
|
2.9414e-05
|
|
|
CPB1
|
[NCBI]
|
2.9414e-05
|
|
|
CDKAL1
|
[NCBI]
|
2.9414e-05
|
|
|
HYOU1
|
[NCBI]
|
2.9414e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
2.91609e-05
|
|
|
ACHE
|
[NCBI]
|
2.85971e-05
|
|
|
CRC
|
[NCBI]
|
2.8547e-05
|
|
|
TH
|
[NCBI]
|
2.8383e-05
|
|
|
MC4R
|
[NCBI]
|
2.83532e-05
|
|
|
JBS
|
[NCBI]
|
2.78166e-05
|
|
|
SORBS1
|
[NCBI]
|
2.74554e-05
|
|
|
PTPRN
|
[NCBI]
|
2.74554e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
2.74554e-05
|
|
|
ERBB3
|
[NCBI]
|
2.74554e-05
|
|
|
PHA
|
[NCBI]
|
2.65902e-05
|
|
|
FXN
|
[NCBI]
|
2.61223e-05
|
|
|
donohue syndrome
|
[NCBI]
|
2.60155e-05
|
|
|
EIF2AK3
|
[NCBI]
|
2.58339e-05
|
|
|
ICOS
|
[NCBI]
|
2.58339e-05
|
|
|
IL23R
|
[NCBI]
|
2.58339e-05
|
|
|
INSIG2
|
[NCBI]
|
2.58339e-05
|
|
|
GYS1
|
[NCBI]
|
2.58339e-05
|
|
|
CGL2
|
[NCBI]
|
2.49337e-05
|
|
|
REG3A
|
[NCBI]
|
2.47929e-05
|
|
|
PIK3R1
|
[NCBI]
|
2.4452e-05
|
|
|
PDE4D
|
[NCBI]
|
2.4452e-05
|
|
|
PCSK1
|
[NCBI]
|
2.4452e-05
|
|
|
HK2
|
[NCBI]
|
2.4452e-05
|
|
|
CCAL2
|
[NCBI]
|
2.44235e-05
|
|
|
IDE
|
[NCBI]
|
2.35689e-05
|
|
|
AKT2
|
[NCBI]
|
2.32492e-05
|
|
|
BWS
|
[NCBI]
|
2.28525e-05
|
|
|
CCKAR
|
[NCBI]
|
2.21854e-05
|
|
|
TFE3
|
[NCBI]
|
2.21854e-05
|
|
|
NSF
|
[NCBI]
|
2.21854e-05
|
|
|
ASIP
|
[NCBI]
|
2.21854e-05
|
|
|
SPINK1
|
[NCBI]
|
2.15878e-05
|
|
|
IGER
|
[NCBI]
|
2.1314e-05
|
|
|
H6PD
|
[NCBI]
|
2.12327e-05
|
|
|
APOM
|
[NCBI]
|
2.12327e-05
|
|
|
MAPK8
|
[NCBI]
|
2.03708e-05
|
|
|
FOXO3A
|
[NCBI]
|
2.03708e-05
|
|
|
TFPI
|
[NCBI]
|
2.0366e-05
|
|
|
BDNF
|
[NCBI]
|
2.01497e-05
|
|
|
AIMAH
|
[NCBI]
|
1.98238e-05
|
|
|
CAV1
|
[NCBI]
|
1.88621e-05
|
|
|
IGFALS
|
[NCBI]
|
1.86247e-05
|
|
|
F3
|
[NCBI]
|
1.8563e-05
|
|
|
ATF6
|
[NCBI]
|
1.81945e-05
|
|
|
PTPN22
|
[NCBI]
|
1.81945e-05
|
|
|
AIRE
|
[NCBI]
|
1.78147e-05
|
|
|
GK
|
[NCBI]
|
1.75744e-05
|
|
|
GRB2
|
[NCBI]
|
1.75744e-05
|
|
|
FA
|
[NCBI]
|
1.74819e-05
|
|
|
ADRB3
|
[NCBI]
|
1.69957e-05
|
|
|
CFB
|
[NCBI]
|
1.64537e-05
|
|
|
MG
|
[NCBI]
|
1.62439e-05
|
|
|
PYY
|
[NCBI]
|
1.62205e-05
|
|
|
LBR
|
[NCBI]
|
1.59442e-05
|
|
|
C4B
|
[NCBI]
|
1.59442e-05
|
|
|
LPA
|
[NCBI]
|
1.59442e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
1.59442e-05
|
|
|
G6PC2
|
[NCBI]
|
1.54638e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
1.54638e-05
|
|
|
IL1B
|
[NCBI]
|
1.54638e-05
|
|
|
DDIT3
|
[NCBI]
|
1.54638e-05
|
|
|
NGFB
|
[NCBI]
|
1.52231e-05
|
|
|
REST
|
[NCBI]
|
1.50096e-05
|
|
|
GALP
|
[NCBI]
|
1.45791e-05
|
|
|
CEL
|
[NCBI]
|
1.45791e-05
|
|
|
EMD
|
[NCBI]
|
1.45791e-05
|
|
|
LCT
|
[NCBI]
|
1.45791e-05
|
|
|
AD
|
[NCBI]
|
1.43949e-05
|
|
|
CP
|
[NCBI]
|
1.35409e-05
|
|
|
FOXO1A
|
[NCBI]
|
1.34096e-05
|
|
|
CAT
|
[NCBI]
|
1.325e-05
|
|
|
CDK4
|
[NCBI]
|
1.31038e-05
|
|
|
ADA
|
[NCBI]
|
1.25847e-05
|
|
|
SRS
|
[NCBI]
|
1.15265e-05
|
|
|
TFPI2
|
[NCBI]
|
1.14901e-05
|
|
|
ATF3
|
[NCBI]
|
1.14901e-05
|
|
|
HGPS
|
[NCBI]
|
1.14393e-05
|
|
|
IBD1
|
[NCBI]
|
1.12749e-05
|
|
|
PRL
|
[NCBI]
|
1.12696e-05
|
|
|
SOCS3
|
[NCBI]
|
1.12124e-05
|
|
|
MTTK
|
[NCBI]
|
1.09447e-05
|
|
|
CD36
|
[NCBI]
|
1.06865e-05
|
|
|
GC
|
[NCBI]
|
1.06865e-05
|
|
|
AGT
|
[NCBI]
|
1.06865e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.04371e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.04371e-05
|
|
|
IRS1
|
[NCBI]
|
1.04371e-05
|
|
|
CFTR
|
[NCBI]
|
1.04181e-05
|
|
|
TFR2
|
[NCBI]
|
1.01961e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
9.73737e-06
|
|
|
NOD2
|
[NCBI]
|
9.30692e-06
|
|
|
SDC2
|
[NCBI]
|
9.01997e-06
|
|
|
TG
|
[NCBI]
|
8.98011e-06
|
|
|
LS
|
[NCBI]
|
8.97915e-06
|
|
|
VEGF
|
[NCBI]
|
8.8643e-06
|
|
|
ANG
|
[NCBI]
|
8.70835e-06
|
|
|
MC1R
|
[NCBI]
|
8.15944e-06
|
|
|
APOE
|
[NCBI]
|
6.69818e-06
|
|
|
TTR
|
[NCBI]
|
5.92456e-06
|
|
|
CTGF
|
[NCBI]
|
5.49806e-06
|
|
|
BBS
|
[NCBI]
|
5.49026e-06
|
|
|
VHL
|
[NCBI]
|
5.41257e-06
|
|
|
CPB2
|
[NCBI]
|
5.29112e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
5.08267e-06
|
|
|
IHH
|
[NCBI]
|
4.88271e-06
|
|
|
GDNF
|
[NCBI]
|
4.32077e-06
|
|
|
STAT3
|
[NCBI]
|
4.28018e-06
|
|
|
LDLR
|
[NCBI]
|
3.96148e-06
|
|
|
CMH
|
[NCBI]
|
3.86961e-06
|
|
|
RASA1
|
[NCBI]
|
3.76019e-06
|
|
|
PWS
|
[NCBI]
|
3.0701e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
2.88081e-06
|
|
|
PON1
|
[NCBI]
|
2.59483e-06
|
|
|
PLTP
|
[NCBI]
|
2.59483e-06
|
|
|
KDR
|
[NCBI]
|
2.38288e-06
|
|
|
PTH
|
[NCBI]
|
2.32063e-06
|
|
|
BCHE
|
[NCBI]
|
2.04577e-06
|
|
|
GAL
|
[NCBI]
|
2.04577e-06
|
|
|
TSD
|
[NCBI]
|
1.99535e-06
|
|
|
AVP
|
[NCBI]
|
1.76665e-06
|
|
|
MB
|
[NCBI]
|
1.66839e-06
|
|
|
FRAP1
|
[NCBI]
|
1.66063e-06
|
|
|
SOD2
|
[NCBI]
|
1.41941e-06
|
|
|
CNTF
|
[NCBI]
|
9.67869e-07
|
|
|
VIP
|
[NCBI]
|
9.04174e-07
|
|
|
SPP1
|
[NCBI]
|
9.01105e-07
|
|
|
NPPA
|
[NCBI]
|
8.73859e-07
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
8.54331e-07
|
|
|
SHH
|
[NCBI]
|
7.04188e-07
|
|
|
GAPDH
|
[NCBI]
|
7.04188e-07
|
|
|
PEDF
|
[NCBI]
|
7.01489e-07
|
|
|
ADM
|
[NCBI]
|
6.19743e-07
|
|
|
OSM
|
[NCBI]
|
5.08912e-07
|
|
|
G6PD
|
[NCBI]
|
5.00865e-07
|
|
|
COMT
|
[NCBI]
|
4.39639e-07
|
|
|
ALB
|
[NCBI]
|
4.18913e-07
|
|
|
TPO
|
[NCBI]
|
3.33216e-07
|
|
|
VDR
|
[NCBI]
|
2.52446e-07
|
|
|
COMP
|
[NCBI]
|
1.89321e-07
|
|
|
SHBG
|
[NCBI]
|
1.70933e-07
|
|
|
ACE
|
[NCBI]
|
1.6738e-07
|
|
|
CYP1A1
|
[NCBI]
|
9.95921e-08
|
|
|
HFE
|
[NCBI]
|
5.8475e-08
|
|
|
HD
|
[NCBI]
|
4.76736e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.23691e-08
|
|
|
EPO
|
[NCBI]
|
2.50569e-08
|
|
|
amyloidosis vi
|
[NCBI]
|
1.6934e-08
|
|
|
CVID
|
[NCBI]
|
1.07545e-08
|
|
|
GHRH
|
[NCBI]
|
6.2879e-09
|
|
|
FGF7
|
[NCBI]
|
4.81663e-09
|
|
|
AT
|
[NCBI]
|
5.3179e-11
|
|